| Adenosine A2A receptors and basal ganglia physiology SN Schiffmann, G Fisone, R Moresco, RA Cunha, S Ferré Progress in neurobiology 83 (5), 277-292, 2007 | 464 | 2007 |
| In vivo PET study of 5HT2A serotonin and D2 dopamine dysfunction in drug-naive obsessive-compulsive disorder D Perani, V Garibotto, A Gorini, RM Moresco, M Henin, A Panzacchi, ... Neuroimage 42 (1), 306-314, 2008 | 248 | 2008 |
| In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson's disease S Iannaccone, C Cerami, M Alessio, V Garibotto, A Panzacchi, S Olivieri, ... Parkinsonism & related disorders 19 (1), 47-52, 2013 | 241 | 2013 |
| Glucose metabolism and serotonin receptors in the frontotemporal lobe degeneration M Franceschi, D Anchisi, O Pelati, M Zuffi, M Matarrese, RM Moresco, ... Annals of neurology 57 (2), 216-225, 2005 | 192 | 2005 |
| Basal ganglia and language: phonology modulates dopaminergic release M Tettamanti, A Moro, C Messa, RM Moresco, G Rizzo, A Carpinelli, ... Neuroreport 16 (4), 397-401, 2005 | 142 | 2005 |
| In vivo serotonin 5HT(2A) receptor binding and personality traits in healthy subjects: a positron emission tomography study FM Moresco, M Dieci, C Messa, C Gobbo, L Galli, ... Neuroimage 17, 1470 1478, 2002 | 132 | 2002 |
| Therapeutic antibody targeting of Notch1 in T-acute lymphoblastic leukemia xenografts V Agnusdei, S Minuzzo, C Frasson, A Grassi, F Axelrod, S Satyal, ... Leukemia 28 (2), 278-288, 2014 | 131 | 2014 |
| Design, Radiosynthesis, and Biodistribution of a New Potent and Selective Ligand for in Vivo Imaging of the Adenosine A2A Receptor System Using Positron … S Todde, RM Moresco, P Simonelli, PG Baraldi, B Cacciari, G Spalluto, ... Journal of medicinal chemistry 43 (23), 4359-4362, 2000 | 125 | 2000 |
| Axonal damage and loss of connectivity in nigrostriatal and mesolimbic dopamine pathways in early Parkinson's disease SP Caminiti, L Presotto, D Baroncini, V Garibotto, RM Moresco, L Gianolli, ... NeuroImage: Clinical 14, 734-740, 2017 | 123 | 2017 |
| Pre-symptomatic diagnosis in fatal familial insomnia: serial neurophysiological and 18FDG-PET studies P Cortelli, D Perani, P Montagna, R Gallassi, P Tinuper, P Federica, ... Brain 129 (3), 668-675, 2006 | 123 | 2006 |
| 5-HT2A receptor binding is reduced in drug-naive and unchanged in SSRI-responder depressed patients compared to healthy controls: a PET study C Messa, C Colombo, RM Moresco, C Gobbo, L Galli, G Lucignani, ... Psychopharmacology 167, 72-78, 2003 | 119 | 2003 |
| Measurement of regional cerebral glucose utilization with fluorine-18-FDG and PET in heterogeneous tissues: theoretical considerations and practical procedure G Lucignani, KC Schmidt, RM Moresco, G Striano, F Colombo, L Sokoloff, ... Journal of Nuclear Medicine 34 (3), 360-369, 1993 | 108 | 1993 |
| Increased 5-hydroxytryptamine-2 receptor binding in the frontal cortex of depressed patients responding to paroxetine treatment: a positron emission tomography scan study R Zanardi, F Artigas, R Moresco, C Colombo, C Messa, C Gobbo, ... Journal of clinical psychopharmacology 21 (1), 53-58, 2001 | 107 | 2001 |
| In vivo imaging of adenosine A2A receptors in rat and primate brain using [11C]SCH442416 RM Moresco, S Todde, S Belloli, P Simonelli, A Panzacchi, M Rigamonti, ... European journal of nuclear medicine and molecular imaging 32, 405-413, 2005 | 100 | 2005 |
| The status of dopamine nerve terminals in Parkinson's disease and essential tremor: a PET study with the tracer [11-C] FE-CIT A Antonini, RM Moresco, C Gobbo, R De Notaris, A Panzacchi, P Barone, ... Neurological Sciences 22, 47-48, 2001 | 95 | 2001 |
| The Use of Spectral Analysis to Determine Regional Cerebral Glucose Utilization with Positron Emission Tomography and [18F]Fluorodeoxyglucose: Theory … F Turkheimer, RM Moresco, G Lucignani, L Sokoloff, F Fazio, K Schmidt Journal of Cerebral Blood Flow & Metabolism 14 (3), 406-422, 1994 | 91 | 1994 |
| Errors Introduced by Tissue Heterogeneity in Estimation of Local Cerebral Glucose Utilization with Current Kinetic Models of the [18F]Fluorodeoxyglucose Method K Schmidt, G Lucignani, RM Moresco, G Rizzo, MC Gilardi, C Messa, ... Journal of Cerebral Blood Flow & Metabolism 12 (5), 823-834, 1992 | 91 | 1992 |
| GABAA receptor abnormalities in Prader–Willi syndrome assessed with positron emission tomography and [11C] flumazenil G Lucignani, A Panzacchi, L Bosio, RM Moresco, L Ravasi, I Coppa, ... Neuroimage 22 (1), 22-28, 2004 | 90 | 2004 |
| Fluvoxamine treatment and D2 receptors: a pet study on OCD drug-naive patients RM Moresco, L Pietra, M Henin, A Panzacchi, M Locatelli, L Bonaldi, ... Neuropsychopharmacology 32 (1), 197-205, 2007 | 85 | 2007 |
| From cancer metabolism to new biomarkers and drug targets F Chiaradonna, RM Moresco, C Airoldi, D Gaglio, R Palorini, F Nicotra, ... Biotechnology advances 30 (1), 30-51, 2012 | 84 | 2012 |
Silvia Valtorta在 unimib.it 的电子邮件经过验证
